CRP and COVID-19: Some findings from a subgroup analysis of Wuhan research showed CRP can be considered a dependable predictor of adverse outcomes in COVID-19 patients with different disease severity (AUC 0.832, z=10.23, p<0.001; AUC 0.989, z=44.04, p<0.001).